Equillium (EQ) Tax Provisions (2023 - 2024)
Equillium (EQ) reported Tax Provisions of $361000.0 for Q4 2024, down 27.22% quarter-over-quarter from $496000.0 in Q3 2023.
Equillium (EQ) Tax Provisions (2023 - 2024) Analysis & Trends
Equillium (EQ) has 2 years of Tax Provisions data on file, last reported at $361000.0 in Q4 2024.
- Tax Provisions for Q4 2024 came in at $361000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $361000.0 (down 35.99% YoY), and the FY2024 annual result was $361000.0, down 39.83% from the prior year.
- Tax Provisions eased to $361000.0 in Q4 2024 per EQ's latest filing, from $496000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $496000.0 in Q3 2023 and troughed at $8000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 361,000.00 |
| Sep 30, 2023 | 496,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 60,000.00 |